In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 38 for your search:
Trial Type:  Treatment
Treatment/Intervention:  apoptosis induction therapy
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: sim201002, NCT01211002
2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 4 to 50
Sponsor: Other
Protocol IDs: 108128, EudraCT number: 2008-003658-13, NCT00987636
3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: APL-C-001-09, NCT01102426
4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: PANOBIDARA, NCT00840346
5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ZMP-1, 2008-000646-32, NCT00857324
6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01964, S0806, U10CA032102, SWOG-S0806, NCT00972478
7.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: UPCC 15411, NCT01486784
8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 8 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: DIV-NB-201, NCT01592045
9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI
Protocol IDs: 120179, 12-C-0179, NCT01658904
10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LNH-Pro-05, EudraCT Number:2005-004761-42, NCT00842114
11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: ENDOCX, NCT00842491
12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 10 to 15
Sponsor: NCI, Other
Protocol IDs: X080929007, DOD: W81XWH-05-1 0615, NCT00853580
13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 200902024, NCT00853684
14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: AAAB3348, NCT00869050
15.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BZL-101-003, NCT00907959
16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SAHA-I, NCT00918489
17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 51 to 75
Sponsor: Other
Protocol IDs: 08-356, NCT00973752
18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC0986, NCI-2010-02326, 10-004705, CLBH589BUS59T, NCT01261247
19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-90, NCT01327235
20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: Endu-201105, NCT01368419
21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUBX 2011/28, NCT01556035
22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ZhejaingCH-npc-02, NCT01612286
23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120191, 12-C-0191, NCT01681368
24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MC1125, NCI-2012-00518, NCT01737502
25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: J1232, A-17427, NA_00072292, NCT01763931
1   
New Search